The FDA received a biologics license application for accelerated approval of RP1 plus nivolumab for advanced, pretreated ...

The FDA accepted a supplemental new drug application to darolutamide plus androgen deprivation therapy for metastatic hormone ...

The FDA granted a fast track designation to ALE-P02 for patients with CLDN1-positive squamous solid tumors. The FDA granted ...

Clinicians should consider a rapid taper approach for patients with cancer who exhibit repeated signs of opioid misuse, an ...

At a recent Community Case Forum, an expert discussed the risk of cytokine release syndrome after patients undergo CAR T-cell therapy. When treating patients with myeloma with CAR T-cell therapy, it ...

Topical treatments may help ease chemotherapy-induced peripheral neuropathy, but more research is needed. Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients ...

With many patients utilizing medical cannabis, it is important for nurses to be aware of potential drug-drug interactions, an expert said. Cannabis use may impact the efficacy or side effect profile ...